Genovis AB (publ.) Total Assets

Latest as of December 2025: Skr377.93 Million SEK ≈ $40.67 Million USD

Genovis AB (publ.) total assets. Based on the latest financial reports, Genovis AB (publ.) (GENO) holds total assets worth Skr377.93 Million SEK (≈ $40.67 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Genovis AB (publ.) stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Genovis AB (publ.) (2008–2025)

Total assets of Genovis AB (publ.) from 2008 to 2025. This chart illustrates how Genovis AB (publ.)'s total assets have evolved over time, based on quarterly financial data. See today's stock price for Genovis AB (publ.) for real-time trading data and today's change.

Genovis AB (publ.) - Asset Composition Analysis

Genovis AB (publ.) Total Assets Breakdown (December 2025)

Genovis AB (publ.) total assets breakdown as of December 2025. Genovis AB (publ.)'s total assets of Skr377.93 Million consist of 54.7% current assets and 45.3% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr163.19 Million	43.2%
Accounts Receivable	Skr0.00	0.0%
Inventory	Skr0.00	0.0%
Property, Plant & Equipment	Skr83.93 Million	22.2%
Intangible Assets	Skr79.30 Million	21.0%
Goodwill	Skr0.00	0.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Genovis AB (publ.)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Genovis AB (publ.) current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Genovis AB (publ.)'s current assets represent 54.7% of total assets in 2025, an increase from 7.6% in 2008.
Cash Position: Cash and equivalents constituted 43.2% of total assets in 2025, up from 1.2% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 20.0% of total assets, an increase from 2.0% in 2008.
Asset Diversification: The largest asset category is cash and equivalents at 43.2% of total assets.

Genovis AB (publ.) Competitors by Total Assets

Key competitors of Genovis AB (publ.) based on total assets are shown below.

Company	Country	Total Assets
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	USA	$1.26 Billion
Verona Pharma plc F:I9SA	Germany	€572.87 Million
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	USA	$641.76 Million
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.46 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Bavarian Nordic CO:BAVA	Denmark	Dkr14.95 Billion
Hebei Changshan Biochem Pharma SHE:300255	China	CN¥4.66 Billion

Genovis AB (publ.) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	7.36	7.38	5.19
Quick Ratio	7.36	6.91	5.19
Cash Ratio	5.81	6.01	0.00
Working Capital	Skr178.55 Million	Skr179.99 Million	Skr59.09 Million

Genovis AB (publ.) - Advanced Valuation Insights

This section examines the relationship between Genovis AB (publ.)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.26
Latest Market Cap to Assets Ratio	0.40
Asset Growth Rate (YoY)	15.4%
Total Assets	Skr377.93 Million
Market Capitalization	$150.36 Million USD

Valuation Analysis

Below Book Valuation: The market values Genovis AB (publ.)'s assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Genovis AB (publ.)'s assets grew by 15.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Genovis AB (publ.) (2008–2025)

The table below shows the annual total assets of Genovis AB (publ.) from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	Skr377.93 Million ≈ $40.67 Million	+15.43%
2024-12-31	Skr327.41 Million ≈ $35.23 Million	+13.35%
2023-12-31	Skr288.86 Million ≈ $31.09 Million	+91.91%
2022-12-31	Skr150.52 Million ≈ $16.20 Million	+6.19%
2021-12-31	Skr141.75 Million ≈ $15.25 Million	+32.91%
2020-12-31	Skr106.65 Million ≈ $11.48 Million	+117.45%
2019-12-31	Skr49.04 Million ≈ $5.28 Million	+29.65%
2018-12-31	Skr37.83 Million ≈ $4.07 Million	+43.80%
2017-12-31	Skr26.31 Million ≈ $2.83 Million	+20.38%
2016-12-31	Skr21.85 Million ≈ $2.35 Million	+29.19%
2015-12-31	Skr16.91 Million ≈ $1.82 Million	-13.54%
2014-12-31	Skr19.56 Million ≈ $2.11 Million	-52.80%
2013-12-31	Skr41.45 Million ≈ $4.46 Million	+128.26%
2012-12-31	Skr18.16 Million ≈ $1.95 Million	-15.31%
2011-12-31	Skr21.44 Million ≈ $2.31 Million	+20.34%
2010-12-31	Skr17.82 Million ≈ $1.92 Million	+20.72%
2009-12-31	Skr14.76 Million ≈ $1.59 Million	-1.73%
2008-12-31	Skr15.02 Million ≈ $1.62 Million	--

About Genovis AB (publ.)

ST:GENO Sweden Biotechnology

Market Cap

$150.36 Million

Skr1.40 Billion SEK

Market Cap Rank

#17478 Global

#298 in Sweden

Share Price

Skr21.15

Change (1 day)

-0.47%

52-Week Range

Skr16.16 - Skr23.00

All Time High

Skr87.00